1
|
Ikeda M, Tsuno S, Sugiyama T, Hashimoto A, Yamoto K, Takeuchi K, Kishi H, Mizuguchi H, Kohsaka SI, Yoshioka T. Ca(2+) spiking activity caused by the activation of store-operated Ca(2+) channels mediates TNF-α release from microglial cells under chronic purinergic stimulation. Biochim Biophys Acta 2013; 1833:2573-2585. [PMID: 23830920 DOI: 10.1016/j.bbamcr.2013.06.022] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/21/2012] [Revised: 06/21/2013] [Accepted: 06/24/2013] [Indexed: 02/07/2023]
Abstract
Cytokines released from microglia mediate defensive responses in the brain, but the underlying mechanisms are obscure. One proposed process is that nucleotide leakage or release from surrounding cells is sensed by metabotropic (P2Y) and ionotropic (P2X) purinergic receptors, which may trigger long-term intracellular Ca(2+) flux and tumor necrosis factor α (TNF-α) release. Indeed, 3h of exposure to ATP was required to evoke TNF-α release from a murine microglial cell line (MG5). A Ca(2+) chelator, ethylene glycol tetraacetic acid (EGTA), reduced ATP-induced TNF-α release, suggesting that intracellular Ca(2+) is important in this response. Therefore, Ca(2+) sensor genes (YC3.6) were transfected into MG5 cells to investigate the Ca(2+) dynamics underlying ATP-induced TNF-α release. The results demonstrated ATP-induced biphasic Ca(2+) mobilization mediated by P2Y (~5min) and P2X7 receptors (5-30min). Moreover, Ca(2+) spiking activity in cell processes progressively increased with a reduction in P2X7 receptor-mediated Ca(2+) elevation during 3-h ATP stimulation. Increased Ca(2+) spiking activity paralleled the reduction in thapsigargin-sensitive internal Ca(2+) stores, dendrite extension, and expression of macrophage scavenger receptors with collagenous structure. The Ca(2+) spiking activity was enhanced by a P2X7 receptor antagonist (A438079), but inhibited by a store-operated channel antagonist (SKF96365) or by co-transfection of small interference ribonucleic acid (siRNA) targeted on the channel component (Orai1). Furthermore, ATP-induced TNF-α release was enhanced by A438079 but was inhibited by SKF96365. Because store-operated channels (Stim1/Orai1) were expressed both in MG5 and primary microglial cultures, we suggest that P2X7 receptor signaling inhibits store-operated channels during ATP stimulation, and disinhibition of this process gates TNF-α release from microglial cells.
Collapse
Affiliation(s)
- Masayuki Ikeda
- Graduate School of Science and Engineering, University of Toyama, Toyama City, Toyama 930-8555, Japan; Graduate School of Innovative Life Science, University of Toyama, Toyama City, Toyama 930-8555, Japan.
| | - Saki Tsuno
- Graduate School of Science and Engineering, University of Toyama, Toyama City, Toyama 930-8555, Japan
| | - Takashi Sugiyama
- Advanced Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo Shinjuku-ku, Tokyo 169-8555, Japan; Advanced Core Technology Department, Research and Development Division, Corporate R&D Center, Olympus Corporation, Hachioji, Tokyo 192-8512, Japan
| | - Ayami Hashimoto
- Graduate School of Science and Engineering, University of Toyama, Toyama City, Toyama 930-8555, Japan
| | - Kurumi Yamoto
- Graduate School of Science and Engineering, University of Toyama, Toyama City, Toyama 930-8555, Japan
| | - Kouhei Takeuchi
- Graduate School of Innovative Life Science, University of Toyama, Toyama City, Toyama 930-8555, Japan
| | - Hiroyuki Kishi
- Graduate School of Innovative Life Science, University of Toyama, Toyama City, Toyama 930-8555, Japan; Department of Immunology, Faculty of Medicine, University of Toyama, 2630, Sugitani, Toyama 930-01, Japan
| | - Hiroyuki Mizuguchi
- Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka 565-0871, Japan; Laboratory of Stem Cell Regulation, National Institute of Biomedical Innovation, Suita City, Osaka 567-0085, Japan; The Center for Advanced Medical Engineering and Informatics, Osaka University, Suita City, Osaka, 565-0871, Japan
| | - Shin-Ichi Kohsaka
- Department of Neurochemistry, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan
| | - Tohru Yoshioka
- Advanced Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo Shinjuku-ku, Tokyo 169-8555, Japan; Graduate School of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
| |
Collapse
|